Agree, best outcome given the money doesn't get spent and as you said, they still proceed with DD and other prelim work to prove it up. Also, chance to focus/finalise on the new project deal. thats the exciting part imo.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025